State Of Wisconsin Investment Board Athira Pharma, Inc. Transaction History

State Of Wisconsin Investment Board

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.36 - $3.59 $41,772 - $63,543	-17,700 Reduced 41.94%	24,500 $72,000
Q1 2023 May 15, 2023	BUY	$2.26 - $4.22 $61,471 - $114,784	27,200 Added 181.33%	42,200 $105,000
Q4 2022 Feb 14, 2023	BUY	$2.76 - $3.71 $41,400 - $55,650	15,000 New	15,000 $47,000
Q2 2021 Aug 12, 2021	SELL	$10.24 - $20.87 $183,296 - $373,573	-17,900 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$16.48 - $34.3 $294,992 - $613,970	17,900 New	17,900 $613,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $21.6M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.